Syndromic progressive neurodegenerative disease of infancy caused by novel variants in HIBCH: Report of two cases in Colombia.

3-hydroxyisobutyryl-CoA hydrolase deficiency amino acid metabolism hereditary neurodegenerative diseases inborn errors inborn errors of metabolisms seizures

Journal

Intractable & rare diseases research
ISSN: 2186-3644
Titre abrégé: Intractable Rare Dis Res
Pays: Japan
ID NLM: 101586847

Informations de publication

Date de publication:
Aug 2019
Historique:
entrez: 17 9 2019
pubmed: 17 9 2019
medline: 17 9 2019
Statut: ppublish

Résumé

3-Hydroxyisobutyryl-coenzyme A (CoA) hydrolase deficiency (HIBCHD; MIM: #250620) is a rare autosomal recessive inborn error of metabolism caused by a defect in the HIBCH enzyme, resulting in a deficiency of the conversion of 3-hydroxy-isobutyryl-CoA to 3-hydroxy-isobutyric acid, a critical step in valine catabolism. This neurodegenerative disease of infancy is associated with hypotonia, developmental delay, cerebral atrophy and lesions in the basal ganglia on magnetic resonance imaging (MRI). In this study, we describe two unrelated patients with infantile-onset progressive neurodegenerative disease and mutations in HIBCH identified using whole exome sequencing (WES). In Case 1, WES revealed a novel homozygous variant in the

Identifiants

pubmed: 31523596
doi: 10.5582/irdr.2019.01014
pmc: PMC6743429
doi:

Types de publication

Journal Article

Langues

eng

Pagination

187-193

Références

Annu Rev Nutr. 2000;20:457-83
pubmed: 10940342
AJNR Am J Neuroradiol. 2003 Jun-Jul;24(6):1188-91
pubmed: 12812953
Am J Hum Genet. 2007 Jan;80(1):195-9
pubmed: 17160907
Orphanet J Rare Dis. 2013 Dec 04;8:188
pubmed: 24299452
Am J Med Genet A. 2014 Dec;164A(12):3162-9
pubmed: 25251209
Pediatr Neurol. 2015 Mar;52(3):361-5
pubmed: 25591832
Mol Genet Metab. 2015 Aug;115(4):161-7
pubmed: 26026795
Mol Genet Metab. 2015 Aug;115(4):168-73
pubmed: 26163321
Ann N Y Acad Sci. 1989;573:36-54
pubmed: 2634351
Mov Disord. 2016 Nov;31(11):1733-1739
pubmed: 27400804
Mol Genet Metab Rep. 2014 Oct 16;1:455-460
pubmed: 27896122
J Biol Chem. 1970 Jan 10;245(1):183-7
pubmed: 4904089
Ann Neurol. 1982 Mar;11(3):221-32
pubmed: 6807191
Pediatrics. 1982 Oct;70(4):532-8
pubmed: 7122152
J Biol Chem. 1996 Oct 18;271(42):26430-4
pubmed: 8824301

Auteurs

Estephania Candelo (E)

Congenital Abnormalities and Rare Diseases Research Center (CIACER), Faculty of Health Science, Universidad Icesi, Cali, Colombia.
MSc Biomaterials and Tissues Engineering and Genetics of Human Diseases, Bioscience Department, University College London, London, UK.

Léa Cochard (L)

Congenital Abnormalities and Rare Diseases Research Center (CIACER), Faculty of Health Science, Universidad Icesi, Cali, Colombia.
Biology Department, Sciences Po University, Paris, France.

Gabriela Caicedo-Herrera (G)

Congenital Abnormalities and Rare Diseases Research Center (CIACER), Faculty of Health Science, Universidad Icesi, Cali, Colombia.

Ana M Granados (AM)

Radiology and Paediatric Radiologic Department, Fundación Valle del Lili, Cali, Colombia.

Juan F Gomez (JF)

Paediatric Neurology Department, Fundación Valle del Lili, Cali, Colombia.

Lorena Díaz-Ordoñez (L)

Congenital Abnormalities and Rare Diseases Research Center (CIACER), Faculty of Health Science, Universidad Icesi, Cali, Colombia.

Diana Ramirez-Montaño (D)

Congenital Abnormalities and Rare Diseases Research Center (CIACER), Faculty of Health Science, Universidad Icesi, Cali, Colombia.

Harry Pachajoa (H)

Congenital Abnormalities and Rare Diseases Research Center (CIACER), Faculty of Health Science, Universidad Icesi, Cali, Colombia.
Genetic Department, Fundación Valle del Lili, Cali, Colombia.

Classifications MeSH